Hudson Bay Capital Management’s Intelligent Medicine Acquisition Corp. Class A Common Stock IQMD Stock Holding History

Hudson Bay Capital Management’s Portfolio IQMD Stock Details IQMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-249,920	Closed	-$2.57M	–	1136
2022 Q4	$2.57M	Hold	249,920	–	–	0.03%	544
2022 Q3	$2.52M	Sell	249,920 -80	-0%	-$803	0.02%	666
2022 Q2	$2.5M	Hold	250,000	–	–	0.02%	718
2022 Q1	$2.5M	Hold	250,000	–	–	0.03%	633
2021 Q4	$2.48M	Buy	+250,000	New	+$2.47M	0.03%	617

Other funds holding IQMD

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

Walleye Trading New York $87.6B AUM 68.17% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Allworth Financial Folsom, California $24.7B AUM 15.55% 1-Year Est. Return

Hudson Bay Capital Management's IQMD Position: Q1 2023 in Review

Hudson Bay Capital Management sold out of Intelligent Medicine Acquisition Corp. Class A Common Stock (IQMD) in Q1 2023, closing a stake of 249,920 shares — an estimated $2.57M sold.

Hudson Bay Capital Management first reported a position in IQMD in Q4 2021 and held it in 5 quarters. The position peaked at $2.57M in Q4 2022. 8 funds tracked by Wall St. Rank hold IQMD as of Q1 2023.

Hudson Bay Capital Management reported no remaining Intelligent Medicine Acquisition Corp. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
Hudson Bay Capital Management sold 249,920 Intelligent Medicine Acquisition Corp. Class A Common Stock shares in Q1 2023, an estimated $2.57M.
Hudson Bay Capital Management first reported a position in Intelligent Medicine Acquisition Corp. Class A Common Stock in Q4 2021 and held it in 5 quarters.
Hudson Bay Capital Management's Intelligent Medicine Acquisition Corp. Class A Common Stock position peaked at $2.57M in Q4 2022.
8 funds tracked by Wall St. Rank held Intelligent Medicine Acquisition Corp. Class A Common Stock as of Q1 2023.

Based on Hudson Bay Capital Management's 13F filing for Q1 2023, filed 15 May 2023.